Suncoast Equity Management Reduces Holdings in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA)

Suncoast Equity Management reduced its stake in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) by 74.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 22,644 shares of the company’s stock after selling 67,356 shares during the period. Suncoast Equity Management’s holdings in MIRA Pharmaceuticals were worth $26,000 at the end of the most recent quarter.

Separately, International Assets Investment Management LLC purchased a new position in shares of MIRA Pharmaceuticals in the fourth quarter worth $29,000. Hedge funds and other institutional investors own 35.16% of the company’s stock.

MIRA Pharmaceuticals Trading Down 4.3 %

NASDAQ:MIRA opened at $1.11 on Friday. The company has a fifty day moving average of $1.17 and a 200 day moving average of $1.37. MIRA Pharmaceuticals, Inc. has a 52 week low of $0.51 and a 52 week high of $5.01.

MIRA Pharmaceuticals Profile

MIRA Pharmaceuticals, Inc operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.